These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21868465)

  • 1. The relationship of asthma impairment determined by psychometric tools to future asthma exacerbations.
    Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford W; Sajjan S; Allen-Ramey F
    Chest; 2012 Jan; 141(1):66-72. PubMed ID: 21868465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
    J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis.
    Schatz M; Mosen D; Apter AJ; Zeiger RS; Vollmer WM; Stibolt TB; Leong A; Johnson MS; Mendoza G; Cook EF
    J Allergy Clin Immunol; 2005 May; 115(5):1049-55. PubMed ID: 15867865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the asthma control test: a reliable determinant of disease stability and a predictor of future exacerbations.
    Ko FW; Hui DS; Leung TF; Chu HY; Wong GW; Tung AH; Ngai JC; Ng SS; Lai CK
    Respirology; 2012 Feb; 17(2):370-8. PubMed ID: 22107482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between episodes of upper respiratory infection and exacerbations in adult patients with asthma.
    Tomita K; Sano H; Iwanaga T; Ishihara K; Ichinose M; Kawase I; Kimura H; Hirata K; Fujimura M; Mishima M; Tohda Y
    J Asthma; 2012 Apr; 49(3):253-9. PubMed ID: 22376075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of validated psychometric tools to subsequent medical utilization for asthma.
    Schatz M; Mosen D; Apter AJ; Zeiger RS; Vollmer WM; Stibolt TB; Leong A; Johnson MS; Mendoza G; Cook EF
    J Allergy Clin Immunol; 2005 Mar; 115(3):564-70. PubMed ID: 15753905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in asthma control over time: predictors and outcomes.
    Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford W; Sajjan S; Allen-Ramey F
    J Allergy Clin Immunol Pract; 2014; 2(1):59-64. PubMed ID: 24565770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.
    Zeiger RS; Yegin A; Simons FE; Haselkorn T; Rasouliyan L; Szefler SJ; Chipps BE;
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):81-7. PubMed ID: 22289725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma.
    Luskin AT; Chipps BE; Rasouliyan L; Miller DP; Haselkorn T; Dorenbaum A
    J Allergy Clin Immunol Pract; 2014; 2(5):544-52.e1-2. PubMed ID: 25213047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.
    Bateman ED; Buhl R; O'Byrne PM; Humbert M; Reddel HK; Sears MR; Jenkins C; Harrison TW; Quirce S; Peterson S; Eriksson G
    J Allergy Clin Immunol; 2015 Jun; 135(6):1457-64.e4. PubMed ID: 25258144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting future risk of exacerbations in Japanese patients with adult asthma: A prospective 1-year follow up study.
    Tanaka A; Uno T; Sato H; Jinno M; Hirai K; Miyata Y; Yamaguchi M; Ohta S; Homma T; Yamamoto M; Suzuki S; Yokoe T; Sagara H
    Allergol Int; 2017 Oct; 66(4):568-573. PubMed ID: 28318883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical burden and predictors of asthma exacerbations in patients on guideline-based steps 4-6 asthma therapy in the TENOR cohort.
    Calhoun WJ; Haselkorn T; Mink DR; Miller DP; Dorenbaum A; Zeiger RS
    J Allergy Clin Immunol Pract; 2014; 2(2):193-200. PubMed ID: 24607048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the asthma impact survey, a brief asthma-specific quality of life tool.
    Schatz M; Mosen D; Kosinski M; Vollmer WM; O'Connor E; Cook EF; Zeiger RS
    Qual Life Res; 2007 Mar; 16(2):345-55. PubMed ID: 17033905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The strategy for predicting future exacerbation of asthma using a combination of the Asthma Control Test and lung function test.
    Sato R; Tomita K; Sano H; Ichihashi H; Yamagata S; Sano A; Yamagata T; Miyara T; Iwanaga T; Muraki M; Tohda Y
    J Asthma; 2009 Sep; 46(7):677-82. PubMed ID: 19728204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors affecting quality of life in a group of Italian children with asthma.
    Indinnimeo L; Chiarotti F; De Vittori V; Baldini L; De Castro G; Zicari AM; Tancredi G; Leonardi L; Duse M
    Int J Immunopathol Pharmacol; 2014; 27(2):235-44. PubMed ID: 25004835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of asthma score predicts clinical outcomes in patients with moderate to severe persistent asthma.
    Eisner MD; Yegin A; Trzaskoma B
    Chest; 2012 Jan; 141(1):58-65. PubMed ID: 21885725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma-specific quality of life and subsequent asthma emergency hospital care.
    Schatz M; Zeiger RS; Mosen D; Vollmer WM
    Am J Manag Care; 2008 Apr; 14(4):206-11. PubMed ID: 18402513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
    Patel M; Pilcher J; Reddel HK; Qi V; Mackey B; Tranquilino T; Shaw D; Black P; Weatherall M; Beasley R;
    J Allergy Clin Immunol Pract; 2014; 2(6):751-8. PubMed ID: 25439367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure.
    Murphy KR; Chipps B; Beuther DA; Wise RA; McCann W; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Coyne KS; Zeiger RS;
    J Allergy Clin Immunol Pract; 2020; 8(7):2263-2274.e5. PubMed ID: 32387166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK.
    Lloyd A; Price D; Brown R
    Prim Care Respir J; 2007 Feb; 16(1):22-7. PubMed ID: 17297523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.